Thrombosis Action Conference (TAC) 2021 (VIDEOS)

Thrombosis Action Conference: Empowering Clinicians with Evidence-Based Strategies

The Thrombosis Action Conference (TAC) serves as a beacon of medical education, illuminating the path towards improved understanding and management of thromboembolic disorders. This comprehensive conference empowers clinicians with evidence-based strategies to effectively prevent and treat these life-threatening conditions.

Day 1 Agenda:

1. Deciphering the 2020 ESC Guidelines on Atrial Fibrillation: Unraveling the latest advancements in the management of this prevalent heart rhythm disorder.

2. Unveiling the Interplay between Atrial Fibrillation and Diabetes: Exploring innovative approaches to prevent irreversible complications and enhance patient outcomes.

3. The Renal Imperative in Stroke Prevention: Delving into the crucial role of kidney health in mitigating stroke risk and optimizing patient care.

4. Optimizing Protection for Atrial Fibrillation Patients Undergoing PCI: Evaluating the optimal antithrombotic strategies to safeguard patients undergoing percutaneous coronary intervention.

5. Ensuring Safety and Efficacy of Oral Anticoagulation in the Elderly: Assessing the risks and benefits of oral anticoagulants in older adults with atrial fibrillation.

6. Interactive Case Discussion on Atrial Fibrillation: Engaging clinicians in a dynamic discussion of real-world cases to refine their decision-making and patient management skills.

Day 2 Agenda:

1. Panel Session: Dispelling Misconceptions in Atrial Fibrillation: Debunking common myths and uncertainties surrounding this complex condition.

2. Conquering Challenges in Venous Thromboembolism (VTE): Unlocking Solutions with Rivaroxaban:

3. Protection Redefined for VTE Patients: Unveiling the latest insights into the protection provided by Rivaroxaban, a cutting-edge anticoagulant.

4. Navigating Complexities in Cancer-Associated Thrombosis (CAT) Management: Exploring novel strategies to address the unique challenges faced by patients with CAT.

5. Revolutionizing Thrombosis Management in Coronary and Peripheral Artery Disease with Rivaroxaban: Harnessing the power of Rivaroxaban to optimize outcomes in patients with these prevalent vascular conditions.